Accelmed

Type

Venture Capital

Status

Active

Location

Miami, United States

Total investments

44

Average round size

21M

Portfolio companies

26

Rounds per year

2.93

Lead investments

10

Follow on index

0.41

Exits

8

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologyInformation TechnologyMachine LearningHealth CareHealth DiagnosticsHospitalRoboticsManufacturingMedical DeviceMedical

Summary

The company was established in Asia in Israel. The main department of described VC is located in the Tel Aviv.

Among the most popular fund investment industries, there are Health Care, Health Diagnostics. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight EndoGastric Solutions, CartiHeal, Corvia Medical. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - Israel.

The overall number of key employees were 4.

Opposing the other organizations, this Accelmed works on 2 percentage points less the average amount of lead investments. The fund is generally included in 2-6 deals every year. The high activity for fund was in 2015. Despite it in 2019 the fund had an activity. Considering the real fund results, this VC is 35 percentage points more often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top amount of exits for fund were in 2016.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Accelmed, startups are often financed by Elron Electronic Industries, Access Medical Ventures, Third Rock Ventures. The meaningful sponsors for the fund in investment in the same round are Elron Electronic Industries, Access Medical Ventures, Third Rock Ventures. In the next rounds fund is usually obtained by Elron Electronic Industries, Peregrine Ventures, Access Medical Ventures.

Show more

Investor highlights

Industry focus
HealthcareMedtech
Geo focus
United States
Check size
15M — 40M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 400000000
Fund raised date
2021-05-17

Analytics

Total investments
44
Lead investments
10
Exits
8
Rounds per year
2.93
Follow on index
0.41
Investments by industry
  • Health Care (41)
  • Medical Device (26)
  • Medical (12)
  • Biotechnology (11)
  • Hospital (9)
  • Show 28 more
Investments by region
  • United States (23)
  • Israel (21)
Peak activity year
2021
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
14
Avg. valuation at time of investment
27M
Group Appearance index
0.75
Avg. company exit year
15
Avg. multiplicator
2.10
Strategy success index
0.40

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Diagnostic Robotics 13 Nov 2019 Analytics, Artificial Intelligence, Machine Learning, Health Care, Hospital, Robotics Early Stage Venture 24M Israel, Tel Aviv District, Tel Aviv-Yafo
Revamp Medical 30 May 2023 Health Care, Medical Device Early Stage Venture HaMerkaz, Netanya, Israel

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.